Katrin Anne Becker1, Xiang Li2, Aaron Seitz3, Joerg Steinmann4, Anne Koch1, Edward Schuchman5, Markus Kamler6, Michael J Edwards3, Charles C Caldwell3, Erich Gulbins1,3. 1. Department of Molecular Biology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany. 2. Department of Pharmacological & Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas, USA. 3. Department of Surgery, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA. 4. Institute of Medical Microbiology, University of Hospital Essen, University of Duisburg-Essen, Essen, Germany. 5. Department of Genetics & Genomic Sciences, Ichan School of Medicine at Mount Sinai, New York, New York, USA. 6. Department of Thoracic and Cardiovascular Surgery, West German Heart and Vascular Center Essen, University Hospital Essen, Essen, Germany.
Abstract
BACKGROUND/AIMS: Cystic fibrosis (CF) is dominated by chronic inflammation and infection of the lung resulting in lung destruction and early death of patients. The lungs of CF patients are characterized by a massive accumulation of neutrophils. It requires definition why these massive numbers of neutrophils fail to eliminate typical CF pathogens like Staphylococcus aureus and Pseudomonas aeruginosa (P. aeruginosa) in CF lungs. METHODS: We determined ceramide, sphingosine and reactive oxygen species (ROS) in neutrophils from wildtype and CF mice and determined the effect of sphingosine and ROS alone or in combination on killing of different P. aeruginosa strains. RESULTS: We demonstrate that wildtype neutrophils are able to kill non-mucoid and mucoid clinical P. aeruginosa strains, while neutrophils from CF mice are insufficient to kill these P. aeruginosa strains, although both types of neutrophils infected with P. aeruginosa produce comparable levels of superoxide. All three analyzed P. aeruginosa strains are resistant to reactive oxygen species. The inability of CF neutrophils to kill P. aeruginosa is caused by a marked decrease of surface sphingosine levels in CF neutrophils. Wildtype neutrophils contain much higher concentrations of surface sphingosine than CF neutrophils. Further, wildtype neutrophils, but not CF neutrophils, release sphingosine, most likely as microparticles, upon infection. Sphingosine kills P. aeruginosa in vitro at low micromolar concentrations. Reconstitution of sphingosine in CF neutrophils restores their ability to kill these pathogens, demonstrating the significance of sphingosine for bacterial killing. CONCLUSION: The data provide evidence for a new paradigm explaining how neutrophils kill ROS-resistant P. aeruginosa, i.e. by sphingosine that kills P. aeruginosa at low concentrations. This mechanism is defective in CF neutrophils.
BACKGROUND/AIMS: Cystic fibrosis (CF) is dominated by chronic inflammation and infection of the lung resulting in lung destruction and early death of patients. The lungs of CF patients are characterized by a massive accumulation of neutrophils. It requires definition why these massive numbers of neutrophils fail to eliminate typical CF pathogens like Staphylococcus aureus and Pseudomonas aeruginosa (P. aeruginosa) in CF lungs. METHODS: We determined ceramide, sphingosine and reactive oxygen species (ROS) in neutrophils from wildtype and CF mice and determined the effect of sphingosine and ROS alone or in combination on killing of different P. aeruginosa strains. RESULTS: We demonstrate that wildtype neutrophils are able to kill non-mucoid and mucoid clinical P. aeruginosa strains, while neutrophils from CF mice are insufficient to kill these P. aeruginosa strains, although both types of neutrophils infected with P. aeruginosa produce comparable levels of superoxide. All three analyzed P. aeruginosa strains are resistant to reactive oxygen species. The inability of CF neutrophils to kill P. aeruginosa is caused by a marked decrease of surface sphingosine levels in CF neutrophils. Wildtype neutrophils contain much higher concentrations of surface sphingosine than CF neutrophils. Further, wildtype neutrophils, but not CF neutrophils, release sphingosine, most likely as microparticles, upon infection. Sphingosine kills P. aeruginosa in vitro at low micromolar concentrations. Reconstitution of sphingosine in CF neutrophils restores their ability to kill these pathogens, demonstrating the significance of sphingosine for bacterial killing. CONCLUSION: The data provide evidence for a new paradigm explaining how neutrophils kill ROS-resistant P. aeruginosa, i.e. by sphingosine that kills P. aeruginosa at low concentrations. This mechanism is defective in CF neutrophils.
Authors: Karen Keown; Ryan Brown; Declan F Doherty; Claire Houston; Michael C McKelvey; Shannice Creane; Dermot Linden; Daniel F McAuley; Joseph C Kidney; Sinéad Weldon; Damian G Downey; Clifford C Taggart Journal: Int J Mol Sci Date: 2020-09-02 Impact factor: 5.923
Authors: Simon Peters; Lena Kaiser; Julian Fink; Fabian Schumacher; Veronika Perschin; Jan Schlegel; Markus Sauer; Christian Stigloher; Burkhard Kleuser; Jürgen Seibel; Alexandra Schubert-Unkmeir Journal: Sci Rep Date: 2021-02-22 Impact factor: 4.379
Authors: Catherine B Blackwood; Emel Sen-Kilic; Dylan T Boehm; Jesse M Hall; Melinda E Varney; Ting Y Wong; Shelby D Bradford; Justin R Bevere; William T Witt; F Heath Damron; Mariette Barbier Journal: Vaccines (Basel) Date: 2020-11-03
Authors: Nirmal S Sharma; Grant Vestal; Keith Wille; Kapil N Patel; Feng Cheng; Srinivas Tipparaju; Sultan Tousif; Mudassir M Banday; Xin Xu; Landon Wilson; Viswam S Nair; Casey Morrow; Don Hayes; Andreas Seyfang; Stephen Barnes; Jessy S Deshane; Amit Gaggar Journal: Respir Res Date: 2020-05-06